Another interesting finding that possibly contributes to our hypothesis that MMP-9 is linked to systemic inflammation was lower MMP-9 levels among patients with inactive TED formally diagnosed with dyslipidemia and on HMG-CoA reductase inhibitors. The gene discussed is MMP9; the disease is metabolic syndrome.